The Primary Objective of the Study is to Compare Eye Dryness Following LASIK (Laser-Assisted In Situ Keratomileusis) Surgery to Eye Dryness Prior to Receiving Perioperative Miebo in Patients With Dry Eye Disease

Part of paid clinical trials in Bozeman, Montana.

Sponsor
Vance Thompson Vision
Study ID
NCT07650708
Phase
PHASE4
Status
Recruiting

Conditions

  • Dry Eye Disease (DED)
  • Dry Eye Syndrome (DES)

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Miebo four times per day — DRUG
    Single arm study where subjects dose with Miebo four times per day for one month before LASIK and for 1.5 months after LASIK

Study Details

Compare eye dryness following laser-assisted in situ keratomileusis (LASIK) surgery to eye dryness prior to receiving perioperative Miebo in patients with dry eye disease (DED)

Key Dates

Start date
May 5, 2026
Status verified
Jun 2026
Primary completion
Nov 1, 2026
Completion
Dec 1, 2026

Study Design

Enrollment
100 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Active Comparator: Miebo
    Miebo instilled four times per day to each eye

Primary Outcome Measure

Compare eye dryness following laser-assisted in situ keratomileusis (LASIK) surgery to eye dryness prior to receiving perioperative Miebo in patients with dry eye disease (DED) as measured by visual analog scale (VAS) eye dryness score [ Time Frame: 4 months ]

Central Contacts

Locations (4)

FacilityCityStateZIPSite coordinators
Vance Thompson Vision- BozemanBozemanMontana59718
Brianna Cox
605-206-2648
Vance Thompson Vision- OmahaOmahaNebraska68137
Sarah Hartnett
402-899-8020
Vance Thompson Vision- FargoFargoNorth Dakota58078
McKenzie Schueller
701-205-0935
Vance Thompson Vision- Sioux FallsSioux FallsSouth Dakota57108
Kayla Karpuk, OD
605-371-6883

Find similar trials in Bozeman, MT

Related Studies